Synthesis reveals improved biological activity in metal complexes against Pseudomonas and Staphylococcus, suggesting new antibacterial agents.
The synthesis of a new ligand, N4 Tetra (Methel Azometine)-Di Phenylen hydrazide (TMADPH), was carried out by condensing 1,2-diacetylhydrazine with 1,4 -phenylendiamin to obtain the ligand TMADPH. After confirming the structure of the bond using FT–IR, UV–VIS, 1H–NMR and 13C–NMR, its metal complexes with Zr4+, Mn2+and Ni2+ were prepared and studied using FT–IR, UV–VIS spectroscopy, electrical conductivity and metal ratio analysis. The results indicated that all the metal complexes had a mononuclear structure. Furthermore, the biological activity against Pseudomonas aeruginosa and Staphylococcus aureus bacteria was studied, revealing that the prepared metal complexes exhibited greater biological activity than the macrocyclic ligand.
No takes yet. Share an insight, caveat, or question.
Hasan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: